The Lancet in conversation with
Podcast autorstwa The Lancet Group - Piątki
Kategorie:
656 Odcinki
-
The Lancet-Tsinghua Healthy Cities Commission
Opublikowany: 19.04.2018 -
Malaria nets and insecticide resistance
Opublikowany: 12.04.2018 -
NCDs and economics
Opublikowany: 5.04.2018 -
Low back pain
Opublikowany: 22.03.2018 -
Pathology and laboratory medicine
Opublikowany: 15.03.2018 -
Global health journalism
Opublikowany: 9.03.2018 -
Canada's global leadership on health
Opublikowany: 23.02.2018 -
Virtual reality and surgical training
Opublikowany: 16.02.2018 -
Global health in 2018: The Lancet: January 23, 2018
Opublikowany: 23.01.2018 -
Rohingya in Malaysia: The Lancet: January 11, 2018
Opublikowany: 12.01.2018 -
Gene therapy for retinal dystrophy: The Lancet: January 5, 2018
Opublikowany: 6.01.2018 -
You don't know me: The Lancet: December 23, 2017
Opublikowany: 22.12.2017 -
Public availability of trial protocols: The Lancet: December 16, 2017
Opublikowany: 15.12.2017 -
Weight management in type 2 diabetes: The Lancet: December 5, 2017
Opublikowany: 5.12.2017 -
Liver disease: The Lancet: November 29, 2017
Opublikowany: 29.11.2017 -
Heart failure incidence: The Lancet: November 21, 2017
Opublikowany: 22.11.2017 -
Lancet Countdown 2017: The Lancet: October 30, 2017
Opublikowany: 31.10.2017 -
Conflict in Colombia: The Lancet: October 26, 2017
Opublikowany: 27.10.2017 -
The Lancet Commission on Pollution and Health: October 19, 2017
Opublikowany: 20.10.2017 -
Palliative Care and Pain Relief: The Lancet: October 12, 2017
Opublikowany: 13.10.2017
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.